Monday - Friday
8:30AM to 5:30PM CET

Can't find your specific product? Send us an enquiry in our form!

Modified Phosphoramidites

We are thrilled to announce that Summit Pharmaceuticals Europe is now promoting new modified nucleic acids (phosphoramidites) from Luxna Biotech Co., Ltd.(“Luxna”), a leading biotech company in Japan specializing in the research and development of oligonucleotide therapeutics.

DAIB (Diacetoxyiodo)benzene (CAS 3240-34-4) / DAIM (Diacetoxyiodo)mesitylene (CAS 33035-41-5)

Low-toxic versatile oxidizing agents based on hypervalent iodine.
DAIM is particularly suited for use with low-polar solvents.

D-Epoxone (CAS 18422-53-2)

Asymmetric epoxidation catalyst for the production of chiral epoxides. High-purity, heavy metal-free. Eco-friendly production process.

Buchwald Phosphine Ligands

Highly-effective ligands for Pd-catalyzed cross-coupling reactions.

See you at CPhI China 2026!

June 11, 2026

Why meet Summit Pharmaceuticals Europe at CPHI 2026 [Booth E2E70]?

  • Global reach, local expertise
    We combine a strong international network with deep knowledge of the European and Japanese markets.
  • End-to-end support
    From sourcing and development to commercialization, we help you accelerate your projects with reliable partners.
  • Tailored solutions
    Whether you are a pharma company, CDMO, or manufacturer, we provide flexible and customized approaches to meet your needs.

👉 Book a meeting with our team to explore new collaboration opportunities and take your projects forward with a trusted partner.

Other news